Morgenroth, Carla Lou http://orcid.org/0000-0001-9048-5264
Kleymann, Philipp
Ripke, Stephan http://orcid.org/0000-0003-3622-835X
Awasthi, Swapnil http://orcid.org/0000-0002-9692-8123
Wagner, Elias http://orcid.org/0000-0002-7147-6167
Oviedo-Salcedo, Tatiana
Okhuijsen-Pfeifer, Cynthia
Luykx, Jurjen J. http://orcid.org/0000-0002-6439-2774
van der Horst, Marte Z.
Hasan, Alkomiet
Bermpohl, Felix
Gutwinski, Stefan
Schreiter, Stefanie http://orcid.org/0000-0001-9598-0029
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 3 November 2022
Accepted: 14 March 2023
First Online: 5 April 2023
Declarations
:
: The authors declare that they have no conflict of interest with regard to the content of this report. A. Hasan has received paid speakerships from Janssen, Recordati, Otsuka, and Lundbeck. He was a member of Roche, Otsuka, Lundbeck, Recordati, Rovi, and Janssen advisory boards. He is editor of the WFSBP and the German AWMF-S3 schizophrenia guidelines.
: Written informed consent was obtained from all individual participants included in the study.
: The study has been approved by the appropriate ethics committee and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All persons gave their informed consent prior to their inclusion in the study. Approval was granted by the Ethics Committee of the University Hospital of Munich (LMU Munich) (Reference number 458-16) and the ethics committee of the University Medical Center Utrecht (Reference numbers 15-306/15-312).